Chiara F. Sugrue, MBA, MS, SCT(ASCP)

More documents

Recommendations

Info

I have nothing to disclose 2
EXTENDED ROLE OF CYTOTECHNOLOGISTS 1. Screening and interpretation: Gyn, Non‐Gyn, FNA • Screening IHC 2. FNA Adequacy Assessment: superficial, CT scan, EBUS, EUS • Ultrasound assistance • Effective communication with clinicians 3. Quality control/assurance 4. Molecular testing: HPV, EGFR 5. FISH: Urovysion 6. Circulating Tumor Cell Testing 7. Grossing 8. Education, as part of the academic team in Pathology Residency & Cytopathology Fellowship 3
Page 1: CHIARA SUGRUE, MBA, MS, SCT(ASCP)CM
Page 5 and 6: FNA Rapid On‐Site Assessment of A
Page 7 and 8: FNA Rapid Onsite Assessment of Adeq
Page 9 and 10: FNA TEAM @ NSLIJHS Laboratories Fro
Page 11 and 12: FNA Rapid On‐Site Assessment of A
Page 13 and 14: Lab productivity loss: example Spec
Page 15 and 16: DISADVANTAGE: Inadequate service co
Page 17 and 18: • New ways to apply technology
Page 19 and 20: Telepathology validation at NSLIJHS
Page 21 and 22: Option 3: Propose a new CPT code fo
Page 23 and 24: New model for FNA rapid on‐site A

Chiara F. Sugrue, MBA, MS, SCT(ASCP)

Create successful ePaper yourself

Delete template?

Save as template?